ALLO-316 in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): Updated Safety and Efficacy From the Phase 1 TRAVERSE Multicenter Study

• Post author:andrewkaretas
• Post published:November 7, 2024
• Post category:CD70/Scientific Publications

Continue ReadingALLO-316 in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC): Updated Safety and Efficacy From the Phase 1 TRAVERSE Multicenter Study

TRAVERSE: A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ALLO-316 in Patients with Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)

• Post author:andrewkaretas
• Post published:April 6, 2023
• Post category:CD70/Scientific Publications

Continue ReadingTRAVERSE: A Phase 1 Multicenter Study Evaluating the Safety and Efficacy of ALLO-316 in Patients with Advanced or Metastatic Clear Cell Renal Cell Carcinoma (ccRCC)

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma

• Post author:andrewkaretas
• Post published:April 20, 2022
• Post category:CD70/Scientific Publications

Continue ReadingPreclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma

Preclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma

• Post author:andrewkaretas
• Post published:April 18, 2022
• Post category:CD70/Scientific Publications

Continue ReadingPreclinical Development and Evaluation of Allogeneic CAR T Cells Targeting CD70 for the Treatment of Renal Cell Carcinoma

Investigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML

• Post author:andrewkaretas
• Post published:December 18, 2020
• Post category:CD70/Scientific Publications

Continue ReadingInvestigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML

American Association for Cancer Research (AACR) April 2019 – AlloCAR T™ Targeting CD70 For RCC

• Post author:andrewkaretas
• Post published:April 18, 2019
• Post category:CD70/Scientific Publications

Continue ReadingAmerican Association for Cancer Research (AACR) April 2019 – AlloCAR T™ Targeting CD70 For RCC